Loading insider details...
Latest Form 4 (Nov 4, 2026): Sale of 6,582 FATE shares, $13.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 4, 2026 | FATE THERAPEUTICS INC (FATE) | Sale | 6,582 | $13.5K |
| Jan 16, 2026 | FATE THERAPEUTICS INC (FATE) | Grant/Award | 25,000 | n/a |
| Oct 21, 2025 | FATE THERAPEUTICS INC (FATE) | Grant/Award | 75,000 | n/a |
| Mar 6, 2024 | EXAGEN INC. (XGN) | Sale | 9,297 | $17.7K |
| Feb 22, 2024 | EXAGEN INC. (XGN) | Grant/Award | 75,000 | n/a |
| Feb 8, 2024 | EXAGEN INC. (XGN) | Sale | 6,738 | $13.1K |
| Mar 3, 2023 | EXAGEN INC. (XGN) | Sale | 3,667 | $8.4K |
| Mar 1, 2023 | EXAGEN INC. (XGN) | Grant/Award | 100,000 | n/a |
| Feb 10, 2023 | EXAGEN INC. (XGN) | Sale | 5,821 | $15.7K |
| Mar 2, 2022 | EXAGEN INC. (XGN) | Tax Withholding | 3,241 | $23.1K |